Lipigon Pharmaceuticals AB (publ) (FRA:9RP)
Germany
· Delayed Price · Currency is EUR 0.0010
-0.0024 (-70.59%)
At close: Dec 5, 2025
FRA:9RP Market Cap
FRA:9RP has a market cap or net worth of €663.60 thousand as of December 5, 2025. Its market cap has decreased by -61.84% in one year.
Market Cap
663.60K
Enterprise Value
-851.11K
Revenue
119.12K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since March 1, 2021, FRA:9RP's market cap has decreased from 9.62M to 663.60K, a decrease of -93.10%. That is a compound annual growth rate of -42.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 640.65K | -57.11% |
| Dec 30, 2024 | 1.49M | -69.44% |
| Dec 29, 2023 | 4.89M | 240.47% |
| Dec 30, 2022 | 1.44M | -76.76% |
| Dec 30, 2021 | 6.18M | -35.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |